{"id":219033,"date":"2026-03-02T08:03:00","date_gmt":"2026-03-02T13:03:00","guid":{"rendered":"https:\/\/news-you-need.com\/index.php\/2026\/03\/02\/rare-disease-research-challenges-explained\/"},"modified":"2026-03-02T08:05:12","modified_gmt":"2026-03-02T13:05:12","slug":"rare-disease-research-challenges-explained","status":"publish","type":"post","link":"https:\/\/news-you-need.com\/index.php\/2026\/03\/02\/rare-disease-research-challenges-explained\/","title":{"rendered":"Rare Disease Research Challenges Explained"},"content":{"rendered":"

Rare Disease Research Challenges Explained<\/a><\/p>\n

https:\/\/www.technologynetworks.com\/tn\/articles\/rare-disease-research-exploring-the-barriers-in-drug-development-410200<\/a><\/p>\n

Publish Date: 2026-03-02 08:03:00<\/a><\/p>\n

Source Domain: www.technologynetworks.com<\/a><\/p>\n

The definition of a rare disease varies by location. In the United States, a condition affecting fewer than 1 in 200,000 people is considered rare, whereas in the European Union, this number is much lower at 1 in 2,000. However, one thing that remains consistent worldwide is inequitable access to treatment for people living with <\/span>rare diseases<\/span> (PLWRD).<\/span><\/p>\n

This is driven by multiple factors, not least the unavailability of existing therapies. This often arises due to <\/span>challenges<\/span> throughout the drug development pipeline, from research to regulation. For example, the rarity of these diseases and the geographic distribution of patients <\/span>complicates clinical trial development<\/span>, and even when a drug makes it through trials and is approved for use, lack of funding often prevents patient access.<\/span><\/p>\n

Worldwide, more than <\/span>400 million<\/span> people live with rare diseases, which are often progressive and life-limiting in nature. This places considerable strain on PLWRD and their loved ones, as well as creating broader socioeconomic challenges.<\/span><\/p>\n

Following a recent unanimous vote by the World Health Assembly to make rare diseases a\u00a0<\/span>global health priority<\/span>, more must be done to address the unmet needs of PLWRD.<\/span><\/p>\n


<\/span>To learn more about the challenges faced in rare disease drug development and manufacturing, Technology Networks\u00a0asked an array of experts the same question: \u201c<\/span>What would you consider to be the biggest challenge companies face when developing and manufacturing drugs for rare diseases?\u201d<\/span><\/p>\n

In parts two and three of this series, experts will cover the significance of treatment access for PLWRD and discuss opportunities to target existing inequities.<\/span><\/p>\n

Annabella Amatulli, MSc, Head of Regulatory Affairs, Enterprise Therapeutics<\/span><\/strong><\/span><\/h2>\n

“One of the biggest challenges, in my experience as a regulatory professional, is achieving global regulatory alignment. When developing a drug for a rare disease, patient populations are small. Ideally, you want to run a single,…<\/span><\/p>\n

Source<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Rare Disease Research Challenges Explained https:\/\/www.technologynetworks.com\/tn\/articles\/rare-disease-research-exploring-the-barriers-in-drug-development-410200 Publish Date: 2026-03-02 08:03:00 Source Domain: www.technologynetworks.com The definition…<\/p>\n","protected":false},"author":1,"featured_media":219034,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"fifu_image_url":"https:\/\/assets.technologynetworks.com\/production\/dynamic\/images\/content\/410200\/pills-falling-unsplash-640x360.jpg?cb=20260302","fifu_image_alt":"","footnotes":""},"categories":[8],"tags":[101],"class_list":["post-219033","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-technology","tag-health"],"_links":{"self":[{"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts\/219033"}],"collection":[{"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/comments?post=219033"}],"version-history":[{"count":1,"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts\/219033\/revisions"}],"predecessor-version":[{"id":219035,"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts\/219033\/revisions\/219035"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/media\/219034"}],"wp:attachment":[{"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/media?parent=219033"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/categories?post=219033"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/tags?post=219033"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}